• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现新型基于1,2,3-三唑的杂合物作为血管内皮生长因子受体2(VEGFR2)抑制剂,通过诱导凋亡具有强大的抗增殖和细胞毒性作用。

Discovery of novel tris-1,2,3-triazole-based hybrids as VEGFR2 inhibitors with potent anti-proliferative and cytotoxicity through apoptosis induction.

作者信息

Alsehli Mosa, Sheikh Ali Adeeb Al, Nafie Mohamed S, Bardaweel Sanaa, Aljuhani Ateyatallah, Darwish Khaled M, Alraqa Shaya Yahya, Rezki Nadjet, Aouad Mohamed Reda

机构信息

Department of Chemistry, Faculty of Science, Taibah University, Al-Madinah Al-Munawarah 30002 Saudi Arabia.

Chemistry Department, Kuwait University, Sabah Al Salem University City, Kuwait.

出版信息

Bioorg Chem. 2025 Feb;155:108131. doi: 10.1016/j.bioorg.2025.108131. Epub 2025 Jan 7.

DOI:10.1016/j.bioorg.2025.108131
PMID:39798451
Abstract

The discovery of novel anti-cancer drugs motivated us to synthesize a new series of triple 1,2,3-triazole-based arm scaffolds featuring distinct un functionalized alkyl and/or aryl side chains with possible anti-cancer action using the click chemistry approach under both conventional and green microwave irradiation (MWI) methods. The Cu(I) catalyzed cycloaddition reaction of targeted tris-alkyne with un functionalized aliphatic and aromatic azides has been adopted as an efficient approach for synthesizing the desired click adducts. Microwave irradiation improved the synthetic processes, resulting in higher yields and faster reaction times. Spectroscopic techniques (FT-IR, H, C NMR andCHN analysis) were used for the elucidation of the resulting click structures. The newly synthesized tris-1,2,3-triazoles exhibited promising cytotoxicity, particularly compounds 26 and 28, with IC values of 22.18 µM and 20.3 µM against A549 and CaCo-2 cells, respectively. While they had IC values of 23.06 µM and 21.91 µM against T-47D and CaCo-2 cells, respectively. Both compounds exhibited promising anti-proliferative activity through the wound healing assay. Additionally, both compounds induced total apoptotic cell death by 68.3 % and 58.5 %, respectively, compared to untreated cells (7.7 %). Furthermore, they induced necrotic cell death by 1.4 % and 10.5 %, respectively, compared to 0.1 % in the untreated cells. For the molecular target, compounds 26 and 28 exhibited potent VEGFR2 inhibition with IC values of 35.5 nM and 27.8 nM, respectively, and this was highlighted through the molecular docking findings. Tris-1,2,3-triazoles (26 and 28) exhibited promising cytotoxicity and anti-proliferative against T-47D breast cancer cells through apoptosis and VEGFR2 inhibition using both enzyme kit and western blotting protein expression assays. Molecular docking study highlighted the binding affinity of tested compounds towards the VEGFR2 protein. Accordingly, tris-1,2,3-triazoles (26 and 28) can be further developed as more potent anti-cancer agents.

摘要

新型抗癌药物的发现促使我们使用点击化学方法,在传统和绿色微波辐射(MWI)方法下,合成一系列新的基于1,2,3-三唑的三联臂支架,其具有不同的未官能化烷基和/或芳基侧链,可能具有抗癌作用。已采用铜(I)催化的靶向三炔与未官能化脂肪族和芳香族叠氮化物的环加成反应作为合成所需点击加合物的有效方法。微波辐射改善了合成过程,提高了产率并缩短了反应时间。光谱技术(傅里叶变换红外光谱、氢谱、碳谱和元素分析)用于阐明所得点击结构。新合成的三-1,2,3-三唑表现出有前景的细胞毒性,特别是化合物26和28,对A549和CaCo-2细胞的IC值分别为22.18 μM和20.3 μM。而它们对T-47D和CaCo-2细胞的IC值分别为23.06 μM和21.91 μM。通过伤口愈合试验,这两种化合物均表现出有前景的抗增殖活性。此外,与未处理的细胞(7.7%)相比,这两种化合物分别诱导68.3%和58.5%的细胞发生完全凋亡性死亡。此外,与未处理细胞中的0.1%相比,它们分别诱导1.4%和10.5%的细胞发生坏死性死亡。对于分子靶点,化合物26和28表现出对血管内皮生长因子受体2(VEGFR2)的强效抑制作用,IC值分别为35.5 nM和27.8 nM,这在分子对接研究结果中得到了突出体现。三-1,2,3-三唑(26和28)通过使用酶试剂盒和蛋白质免疫印迹法检测蛋白表达,表现出通过诱导凋亡和抑制VEGFR2对T-47D乳腺癌细胞有前景的细胞毒性和抗增殖作用。分子对接研究突出了测试化合物与VEGFR2蛋白的结合亲和力。因此,三-1,2,3-三唑(26和28)可进一步开发为更有效的抗癌药物。

相似文献

1
Discovery of novel tris-1,2,3-triazole-based hybrids as VEGFR2 inhibitors with potent anti-proliferative and cytotoxicity through apoptosis induction.发现新型基于1,2,3-三唑的杂合物作为血管内皮生长因子受体2(VEGFR2)抑制剂,通过诱导凋亡具有强大的抗增殖和细胞毒性作用。
Bioorg Chem. 2025 Feb;155:108131. doi: 10.1016/j.bioorg.2025.108131. Epub 2025 Jan 7.
2
Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study.新型喹唑啉-2-基 1,2,3-三唑杂合体作为有前途的多靶抗肿瘤剂:设计、合成与分子对接研究。
Bioorg Chem. 2024 Jul;148:107437. doi: 10.1016/j.bioorg.2024.107437. Epub 2024 May 10.
3
Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.靶向VEGFR-2酶的新型三唑并[3,4-a]酞嗪衍生物的设计、合成、体外抗癌活性、ADMET特性及分子对接
Anticancer Agents Med Chem. 2018;18(8):1184-1196. doi: 10.2174/1871520618666180412123833.
4
Ynamide Click chemistry in development of triazole VEGFR2 TK modulators.用于开发三唑类血管内皮生长因子受体2酪氨酸激酶调节剂的ynamide点击化学。
Eur J Med Chem. 2015 Oct 20;103:105-22. doi: 10.1016/j.ejmech.2015.08.012. Epub 2015 Aug 8.
5
Novel benzenesulfonamides as dual VEGFR2/FGFR1 inhibitors targeting breast cancer: Design, synthesis, anticancer activity and in silico studies.新型苯磺酰胺类双重 VEGFR2/FGFR1 抑制剂靶向治疗乳腺癌:设计、合成、抗癌活性及计算机模拟研究。
Bioorg Chem. 2024 Nov;152:107728. doi: 10.1016/j.bioorg.2024.107728. Epub 2024 Aug 17.
6
Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.吲哚三唑缀合物的合成及初步临床评价,作为有效的微管靶向剂,针对 MCF-7 乳腺癌细胞系。
Anticancer Agents Med Chem. 2021;21(8):1047-1055. doi: 10.2174/1871520620666200925102940.
7
Novel bis-benzimidazole-triazole hybrids: anticancer study, in silico approaches, and mechanistic investigation.新型双苯并咪唑-三唑杂化物:抗癌研究、计算机模拟方法及作用机制研究
Future Med Chem. 2025 Jan;17(1):93-107. doi: 10.1080/17568919.2024.2437980. Epub 2024 Dec 13.
8
Synthesis of new functionalized bioactive S-substituted indolyl-triazoles as cytotoxic and apoptotic agents through multi-targeted kinase inhibition.通过多靶点激酶抑制作用合成新型功能化生物活性S-取代吲哚基三唑作为细胞毒性和凋亡诱导剂。
Bioorg Chem. 2025 Mar;156:108154. doi: 10.1016/j.bioorg.2025.108154. Epub 2025 Jan 10.
9
Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studies.鉴定新型[1,2,4]三唑并[4,3-a]喹喔啉类化合物作为有效的 VEGFR-2 酪氨酸激酶抑制剂:设计、合成、抗癌评估和计算机模拟研究。
Bioorg Med Chem. 2021 Sep 15;46:116384. doi: 10.1016/j.bmc.2021.116384. Epub 2021 Aug 28.
10
Discovery of novel indolyl-1,2,4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity.发现新型吲哚-1,2,4-三唑杂合体作为潜在的血管内皮生长因子受体-2(VEGFR-2)抑制剂,具有潜在的抗肾癌活性。
Bioorg Chem. 2020 Dec;105:104330. doi: 10.1016/j.bioorg.2020.104330. Epub 2020 Oct 1.

引用本文的文献

1
Ajuforrestin A Inhibits Tumor Proliferation and Migration by Targeting the STAT3/FAK Signaling Pathways and VEGFR-2.阿朱福瑞司汀A通过靶向STAT3/FAK信号通路和VEGFR-2抑制肿瘤增殖和迁移。
Biology (Basel). 2025 Jul 22;14(8):908. doi: 10.3390/biology14080908.